Tissue Plasminogen Activator and DNase in Empyema REPLY

Tissue Plasminogen Activator and DNase in Empyema REPLY

書誌詳細
主要な著者:	Rahman, N, Maskell, N, Nunn, A
フォーマット:	Journal article
出版事項:	2011

類似資料

Intrapleural use of tissue plasminogen activator and DNase in pleural infection
著者:: Rahman, N, 等
出版事項: (2011)

Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
著者:: Rahman, N, 等
出版事項: (2011)

Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.
著者:: Luengo-Fernandez, R, 等
出版事項: (2019)

The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
著者:: Kanellakis, N, 等
出版事項: (2018)

Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
著者:: Kanellakis, N, 等
出版事項: (2019)

The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients
著者:: Kanellakis, N, 等
出版事項: (2018)

Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
著者:: Benoît Bédat, 等
出版事項: (2019-09-01)

An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
著者:: Estee P.M. Lau, 等
出版事項: (2021-02-01)

Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
著者:: Najib M Rahman, 等
出版事項: (2019-10-01)

The authors reply
著者:: Rahman, N, 等
出版事項: (2011)

Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
著者:: Jason R. McClune, 等
出版事項: (2016-01-01)

Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
著者:: Bapti Roy, 等
出版事項: (2020-10-01)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial
著者:: Michael H. Livingston, 等
出版事項: (2017-06-01)

DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models
著者:: Wusheng Deng, 等
出版事項: (2022-10-01)

A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection
著者:: Ken Junyang Goh, 等
出版事項: (2023-01-01)

Precision targeting of the plasminogen activator inhibitor‐1 mechanism increases efficacy of fibrinolytic therapy in empyema
著者:: Galina Florova, 等
出版事項: (2021-05-01)

Urokinase in the treatment of childhood empyema - Author's reply
著者:: Thomson, A, 等
出版事項: (2003)

The neurotoxicity of tissue plasminogen activator?
著者:: Kaur, J, 等
出版事項: (2004)

TISSUE PLASMINOGEN-ACTIVATOR VERSUS UROKINASE
著者:: Ebers, G
出版事項: (1988)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
著者:: T. Grinenko, 等
出版事項: (2019-12-01)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
著者:: Yu Zuo, 等
出版事項: (2021-01-01)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
著者:: Lihu Gong, 等
出版事項: (2016-03-01)

Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies
著者:: K. Xanthopoulos, 等
出版事項: (2005-11-01)

Intravitreal tissue plasminogen activator in submacular haemorrhage
著者:: Singh Preetam, 等
出版事項: (1999-01-01)

Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
著者:: Nicholas G Kounis, 等
出版事項: (2011-01-01)

Multicomponent synthesis of artificial nucleases and their RNase and DNase activity
著者:: Anton V. Gulevich, 等
出版事項: (2011-08-01)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
著者:: Nurbadriah binti Jasmiad, 等
出版事項: (2022-09-01)

Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis.
著者:: Hua Teng, 等
出版事項: (2012-01-01)

The dependence of DNase I activity on the conformation of oligodeoxynucleotides.
著者:: Sutton, D, 等
出版事項: (1997)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
著者:: Al-Hamodi, Z., 等
出版事項: (2011)

Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects
著者:: Al-Hamodi, Z., 等
出版事項: (2012)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
著者:: Saif-Ali Riyadh, 等
出版事項: (2011-03-01)

Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity
著者:: Ayumi Fukakusa, 等
出版事項: (2008-01-01)

Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
著者:: Yasuhiro Suzuki
出版事項: (2010-01-01)

Drug Dependence, Synaptic Plasticity, and Tissue Plasminogen Activator
著者:: Kiyofumi Yamada, 等
出版事項: (2005-01-01)

Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema
著者:: Idell, S, 等
出版事項: (2019)

Management of parapneumonic effusions and empyema.
著者:: Psallidas, I, 等
出版事項: (2014)

DNase-treated RNA
著者:: Kristie Nybo
出版事項: (2012-04-01)

Salivary Extracellular DNA and DNase Activity in Periodontitis
著者:: Barbora Konečná, 等
出版事項: (2020-10-01)

Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man.
著者:: Pedersen, C, 等
出版事項: (2012)